The company in question is, Juno Therapeutics Inc. (NASDAQ:JUNO) currently with a stock price of 28.12 (2.48% today). The market cap for Juno Therapeutics Inc. is 2879.83, and is in the sector Healthcare, and Biotechnology industry. The target price for Juno Therapeutics Inc. is 44.08. Currently Juno Therapeutics Inc. is trading with a P/E of *TBA, and a forward P/E of *TBA. Average volume for Juno Therapeutics Inc. is 1627.93 and so far today it is 783665.
Performance in the last year for Juno Therapeutics Inc. has been -40.85%. For EPS growth, Juno Therapeutics Inc. has seen a growth of 28.30%, and is looking to grow in the next year to -6.50%. More long term stats show that EPS growth has been *TBA over the last five years and could be *TBA for the next five years. Juno Therapeutics Inc. has seen sales growth quarter over quarter at 120.80%, with EPS growth quarter over quarter at 18.90%. The 20-day simple moving average is -8.25%, with the 200-day simple moving average coming to -21.03%.
Since the IPO date for Juno Therapeutics Inc. on the 12/29/2014, Juno Therapeutics Inc. has seen performance year to date to be -37.59%. With Juno Therapeutics Inc. trading at 28.12, the dividend yield is *TBA, and the EPS is -2.5.
So could Juno Therapeutics Inc., be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 66.82 and the P/B is at 2.4. The P/cash is 3.01, with P/free cash flow at *TBA.
Juno Therapeutics Inc. ability to deal with debt shows that the current ratio is 6.8, and the quick ratio is 6.8. This is with long term debt/equity at 0.03, and total debt/equity at 0.
In terms of margins, Juno Therapeutics Inc. has a gross margin of *TBA, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for Juno Therapeutics Inc. is *TBA. Return on assets come to -16.50% with return on investment coming to -20.30%.
Insider ownership for Juno Therapeutics Inc., is at 4.30% and institutional ownership comes to 76.20%. Outstanding shares are at 104.95. While shares float is 78.37. The float short is currently 14.50%, and short ratio is 6.98.